BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37243243)

  • 1. Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension.
    Oliynyk OV; Rorat M; Strepetova OV; Dubrov SO; Guryanov VG; Oliynyk YV; Kulivets OS; Ślifirczyk A; Barg W
    Viruses; 2023 May; 15(5):. PubMed ID: 37243243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension.
    Hoeper MM; Ewert R; Jansa P; Sirenko Y; Skride A; Balagtas C; Hackley S; Vogt S; Abreu P; Haughie S; Hassan T; Oudiz RJ
    Circulation; 2024 Jun; 149(25):1949-1959. PubMed ID: 38752352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.
    Wirostko BM; Tressler C; Hwang LJ; Burgess G; Laties AM
    BMJ; 2012 Feb; 344():e554. PubMed ID: 22354598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
    Tang Y; Tan S; Li M; Tang Y; Xu X; Zhang Q; Fu Q; Tang M; He J; Zhang Y; Zheng Z; Peng J; Zhu T; Xie W
    BMC Pulm Med; 2022 Apr; 22(1):142. PubMed ID: 35413880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 in a Patient with β-Thalassemia Major and Severe Pulmonary Arterial Hypertension.
    Pinto VM; Derchi GE; Bacigalupo L; Pontali E; Forni GL
    Hemoglobin; 2020 May; 44(3):218-220. PubMed ID: 32552139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of preoperative oral sildenafil on severe pulmonary artery hypertension in patients undergoing mitral valve replacement.
    Gandhi H; Shah B; Patel R; Toshani R; Pujara J; Kothari J; Shastri N
    Indian J Pharmacol; 2014; 46(3):281-5. PubMed ID: 24987174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil for adult Asian patients with pulmonary arterial hypertension: a systematic review and meta-analysis.
    Shi Q; Wang Z; Yang N; Ma Y; Chen Y; Wei H; Yao H
    Ann Palliat Med; 2022 Jan; 11(1):339-351. PubMed ID: 35144425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis.
    Dranitsaris G; Mehta S
    Appl Health Econ Health Policy; 2009; 7(1):43-59. PubMed ID: 19558194
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Peng Y; Dai J; Zhao YY
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial.
    Behr J; Nathan SD; Wuyts WA; Mogulkoc Bishop N; Bouros DE; Antoniou K; Guiot J; Kramer MR; Kirchgaessler KU; Bengus M; Gilberg F; Perjesi A; Harari S; Wells AU
    Lancet Respir Med; 2021 Jan; 9(1):85-95. PubMed ID: 32822614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil for Pulmonary Hypertension in the Early Postoperative Period After Mitral Valve Surgery.
    Ram E; Sternik L; Klempfner R; Eldar M; Goldenberg I; Peled Y; Raanani E; Kogan A
    J Cardiothorac Vasc Anesth; 2019 Jun; 33(6):1648-1656. PubMed ID: 30685151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effect of sildenafil on treating paediatric pulmonary arterial hypertension: a meta-analysis on the randomised controlled trials.
    Zhang Q; Xu B; Lv J; Wang Z; Du J
    Cardiol Young; 2020 Dec; 30(12):1882-1889. PubMed ID: 33077013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
    Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
    Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial.
    Vizza CD; Jansa P; Teal S; Dombi T; Zhou D
    BMC Cardiovasc Disord; 2017 Sep; 17(1):239. PubMed ID: 28874133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil improves renal function in patients with pulmonary arterial hypertension.
    Webb DJ; Vachiery JL; Hwang LJ; Maurey JO
    Br J Clin Pharmacol; 2015 Aug; 80(2):235-41. PubMed ID: 25727860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
    Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
    Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the thromboxane receptor antagonist NTP42 alone, or in combination with sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension.
    Mulvaney EP; Reid HM; Bialesova L; Mendes-Ferreira P; Adão R; Brás-Silva C; Kinsella BT
    Eur J Pharmacol; 2020 Dec; 889():173658. PubMed ID: 33121950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design.
    Behr J; Nathan SD; Harari S; Wuyts W; Kirchgaessler KU; Bengus M; Gilberg F; Wells AU
    Respir Med; 2018 May; 138():13-20. PubMed ID: 29724385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between Sildenafil Use and Changes in Days of Hospitalization in a Population With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.
    Yang X; Sanders KN; Mardekian J; Mychaskiw MA; Thomas J
    Clin Ther; 2015 May; 37(5):1055-63. PubMed ID: 25818118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.